Consultations

Search consultations and choose filters to show only the results you want

Consultation topic

Publication date

368 consultations

Equality and Human Rights Consultation - NICE NG 61 - End of Life Care for Infants, Children and Young People with Life-Limiting Conditions: Planning and Management

Published 07 December 2016Closed

Equality and Human Rights Consultation - NICE TA - Pembrolizumab for Treating PD-L1-Positive Non-Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Published 02 December 2016Closed

Equality and Human Rights Consultation - NICE NG60 - HIV Testing: Increasing Uptake among People who may have Undiagnosed HIV

Published 01 December 2016Closed

Equality and Human Rights Consultation - NICE TA - Mepolizumab for Treating Severe Eosinophilic Asthma

Published 01 December 2016Closed

Equality and Human Rights Consultation - NICE NG58 - Coexisting Severe Mental Illness and Substance Misuse: Community Health and Social Care Services

Published 30 November 2016Closed

Equality and Human Rights Consultation - NICE NG 59 - Low Back Pain and Sciatica in Over 16s: Assessment and Management

Published 30 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Ibrutinib for Previously Treated Chronic Lymphocytic Leukaemia and Untreated Chronic Lymphocytic Leukaemia with 17p Deletion or TP53 Mutation

Published 25 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma (review of TA338)

Published 23 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Dasatinib, Nilotinib and Imatinib for Untreated Chronic Myeloid Leukaemia (Part Review of TA251)

Published 17 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Dasatinib, Nilotinib and High-Dose Imatinib for Treating Imatinib-Resistant or Intolerant Chronic Myeloid Leukaemia (Part Review of TA241) - Section 75 Questionnaire

Published 17 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Pertuzumab for the Neoadjuvant Treatment of HER2-Positive Breast Cancer

Published 17 November 2016Closed

Health and Social Care Transformation – Consultation on Criteria for Reconfiguring Health and Social Care Services

Published 11 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene

Published 10 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Everolimus with Exemestane for Treating Advanced Breast Cancer after Endocrine Therapy

Published 10 November 2016Closed

Equality and Human Rights Consultation - NICE CG 19 - Dental Checks: Intervals between Oral Health Reviews

Published 08 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Ticagrelor for secondary prevention of atherothrombotic events after myocardial infarction [ID813]

Published 04 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Eribulin for treating locally advanced or metastatic breast cancer after two or more prior chemotherapy regimens (Review of TA250) [ID964]

Published 03 November 2016Closed

Equality and Human Rights Consultation - NICE CG 50 - Acutely ill Adults in Hospital: Recognising and Responding to Deterioration - Section 75 Questionnaire

Published 02 November 2016Closed

Equality and Human Rights Consultation - NICE NG 57 - Physical Health of People in Prison - Section 75 Questionnaire

Published 02 November 2016Closed

Equality and Human Rights Consultation - NICE TA - Nivolumab for Treated or Metastatic Renal Cell Carcinoma [ID853]

Published 21 October 2016Closed

Pages

Back to top